ESR1 and neoplasm: TRIM24 was identified as a transcription cofactor of receptors such as estrogen receptor (ER) in breast cancer8 and androgen receptor (AR) in prostate cancer19 to interact with chromatin and these nuclear receptors via its tandem PHD-bromodomain binding to H3K23ac, leading to activation of downstream signaling related with tumor progression.